Abstract
Determination of fetal RHD from maternal plasma is increasingly used as a valuable tool for prenatal diagnosis. A remaining pitfall which hampers its use in situations with severe consequences is the following: (a) The reliability of negative results, however, is limited by difficulties to distinguish true negative results from false negative results due to insufficient amounts of free fetal DNA (ffDNA). False negative results can result in severe complications for the fetus and have to be reliably excluded. Large studies were performed in the last 10 years to investigate the reliability of noninvasive fetal RHD typing with real-time PCR. The majority of the assays were performed without internal controls. We present a protocol for inclusion of standards to assess the presence of adequate amounts of ffDNA for prenatal genotyping in maternal blood.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Daniels G, Finning K, Martin P, Massey E (2009) Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects. Prenatal Diagn 29:101–107
Bischoff FZ, Nguyen DD, Marquez-Do D, Moise KJ Jr, Simpson JL, Elias S (1999) Noninvasive determination of fetal RhD status using fetal DNA in maternal serum and PCR. J Soc Gynecol Investig 6:64–69
Brojer E, Żupanska B, Guz K, Orziñska A, Kaliñska A (2005) Noninvasive determination of fetal RHD status by examination of cell-free DNA in maternal plasma. Transfusion 45:1473–1480
Clausen FB, Krog GR, Rieneck K, Nielsen LK, Lundquist R, Finning K, Dickmeiss E, Hedegaard M, Dziegiel MH (2005) Reliable test for prenatal prediction of fetal RhD type using maternal plasma from RhD negative women. Prenatal Diagn 25:1040–1044
Finning K, Martin P, Summers J, Massey E, Poole G, Daniels G (2008) Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. BMJ 336:816–818
Gassner C, Schmarda A, Kilga-Nogler S, Jenny-Feldkircher B, Rainer E, Müller TH, Wagner FF, Flegel WA, Schönitzer D (1997) RHD/CE typing by polymerase chain reaction using sequence-specific primers. Transfusion 37:1020–1026
Hromadnikova I, Vechetova L, Vesela K, Benesova B, Doucha J, Vlk R (2005) Non-invasive fetal RHD and RHCE genotyping using real-time PCR testing of maternal plasma in RhD-negative pregnancies. J Histochem Cytochem 53:301–305
Legler TJ, Lynen R, Maas JH, Pindur G, Kulenkampff D, Suren A, Osmers R, Köhler M (2002) Prediction of fetal Rh D and Rh CcEe phenotype from maternal plasma with real-time polymerase chain reaction. Transfus Apher Sci 27:217–223
Minon JM, Gerard C, Senterre JM, Schaaps JP, Foidart JM (2008) Routine fetal RHD genotyping with maternal plasma: a four-year experience in Belgium. Transfusion 48:373–381
Müller SP, Bartels I, Stein W, Emons G, Gutensohn K, Köhler M, Legler TJ (2008) The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible. Transfusion 48:2292–2301
Van der Schoot CE, Soussan AA, Koelewijn J, Bonsel G, Paget-Christiaens LGC, de Haas M (2006) Non-invasive antenatal RHD typing. Transfus Clin Biol 13:53–57
Zhang J, Fidler C, Murphy MF, Chamberlain PF, Sargent IL, Redman CW, Hjelm NM, Wainscoat JS, Lo YM (2000) Determination of fetal RhD status by maternal plasma DNA analysis. Ann N Y Acad Sci 906:153–155
Hyland CA, Gardener GJ, Davies H, Ahvenainen M, Flower RL, Irwin D, Morris JM, Ward CM, Hyett JA (2009) Evaluation of non-invasive prenatal RHD genotyping of the fetus. Med J Aust 191:21–25
Randen I, Hauge R, Kjeldsen-Kragh J, Fagerhol MK (2003) Prenatal genotyping of RHD and SRY using maternal blood. Vox Sang 85:300–306
Tounta G, Vrettou C, Kolialexi A, Papantoniou N, Destouni A, Tsangaris GT, Antsaklis A, Kanavakis E, Mavrou A (2011) A multiplex PCR for non-invasive fetal RHD genotyping using cell-free fetal DNA. In Vivo 25:411–417
Tynan JA, Angkachatchai V, Ehrich M, Paladino T, van den Boom D, Oeth P (2011) Multiplexed analysis of circulating cell-free fetal nucleic acids for noninvasive prenatal diagnostic RHD testing. Am J Obstet Gynecol 204:e1–e6
Zhong XY, Holzgreve W, Hahn S (2000) Detection of fetal Rhesus D and sex using fetal DNA from maternal plasma by multiplex polymerase chain reaction. BJOG 107:766–769
Chan KCA, Ding C, Gerovassili A, Yeung SW, Chiu RWK, Leung TN, Lau TK, Chim SSC, Chung GTY, Nicolaides KH, Lo YMD (2006) Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 52:2211–2218
Page-Christiaens GC, Bossers B, van Der Schoot CE, de Haas M (2006) Use of bi-allelic insertion/deletion polymorphisms as a positive control for fetal genotyping in maternal blood. Ann N Y Acad Sci 1075:123–129
Sanchez JJ, Phillips C, Børsting C, Balogh K, Bogus M, Fondevila M, Harrison CD, Musgrave-Brown E, Salas A, Syndercombe-Court D, Schneider PM, Carracedo A, Morling N (2006) A multiplex assay with 52 single nucleotide polymorphisms for human identification. Electrophoresis 27:1713–1724
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Doescher, A., Müller, T.H. (2015). Noninvasive Prenatal Blood Group Genotyping. In: Bugert, P. (eds) Molecular Typing of Blood Cell Antigens. Methods in Molecular Biology, vol 1310. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2690-9_12
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2690-9_12
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2689-3
Online ISBN: 978-1-4939-2690-9
eBook Packages: Springer Protocols